Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

RTI Surgical Announces Agreement with Oxford Performance Materials

RTI Surgical, announced a new agreement with Oxford Performance Materials (OPM), a supplier with a focus in advanced materials and additive manufacturing (3-D printing) for biomedical applications.

The agreement, effective Feb. 4, 2016, grants RTI an exclusive license to OPM’s OsteoFab® technology platform for spinal applications in all U.S. markets. OsteoFab is a next-generation implant manufacturing process that builds implantable medical devices, layer-by-layer, using only laser light and OPM’s OXPEKK® polymer. The OsteoFab process and OXPEKK material combine to create implants that are designed to enable bone ongrowth.
OXPEKK is a proprietary high-performance biocompatible polymer formulation from OPM, designed for medical applications. This strong, pure, radiolucent, hydrophilic, load-bearing material boasts a successful history in orthopaedic implant applications.

Under the agreement, OPM will manufacture RTI’s spinal implant designs using OsteoFab technology, and RTI will oversee finishing steps, packaging, marketing and distribution of finished products.

Source: RTI Surgical

The use of additive manufacturing continues to grow in the orthopaedic market. Stryker recently announced the construction of a state-of-the-art 3D printing manufacturing facility in order to produce new products across multiple divisions and set the company apart from its competitors.